Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells

BACKGROUND: Metastatic, chemotherapy-resistant melanoma is an intractable cancer with a very poor prognosis. As to immunotherapy targeting metastatic melanoma, HLA-A2(+ )patients were mainly enrolled in the study in Western countries. However, HLA-A24(+ )melanoma patients-oriented immunotherapy has...

Descripción completa

Detalles Bibliográficos
Autores principales: Akiyama, Yasuto, Tanosaki, Ryuji, Inoue, Naoki, Shimada, Makiko, Hotate, Yukie, Yamamoto, Akifumi, Yamazaki, Naoya, Kawashima, Ichiro, Nukaya, Ikuei, Takesako, Kazutoh, Maruyama, Kouji, Takaue, Yoichi, Yamaguchi, Ken
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC549033/
https://www.ncbi.nlm.nih.gov/pubmed/15676080
http://dx.doi.org/10.1186/1479-5876-3-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC549033/
https://www.ncbi.nlm.nih.gov/pubmed/15676080
http://dx.doi.org/10.1186/1479-5876-3-4

Ejemplares similares